Related Experiment Video
Updated: Jul 20, 2025

Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
Published on: April 12, 2024
Clinicopathologic features and long-term prognosis of hepatitis B virus-associated glomerulonephritis: a
Hailing Lu1, Yu Li2, Maxiu Lai1
1Department of Nephrology, 900 Hospital of the Joint Logistics Team, PLA, Fuzhou General Clinical Medical College of Fujian Medical University, 156 Xierhuanbei Road, Fuzhou, 350025, Fujian, China.
Insights
Hepatitis B virus-associated glomerulonephritis (HBV-GN) is a serious kidney disease. Hypertension, hyperuricemia, and specific kidney lesions predict poor outcomes, but antiviral therapy may improve prognosis.
Area of Science:
- Nephrology
- Virology
- Immunology
Background:
- Hepatitis B virus-associated glomerulonephritis (HBV-GN) is a common secondary glomerulonephritis in China.
- The clinicopathological features and long-term prognosis of HBV-GN are not fully understood.
Purpose of the Study:
- To explore the clinicopathological features and long-term prognosis of HBV-GN.
- To identify predictors of long-term outcomes in HBV-GN patients.
Main Methods:
- Retrospective analysis of 259 biopsy-proven HBV-GN patients from November 1994 to December 2013.
- Composite endpoints included doubling serum creatinine, end-stage renal disease, or renal death.
- Clinicopathological features and Cox regression analysis were used to identify prognostic predictors.
Main Results:
- The median age was 31 years, with 71% males. Common patterns included IgA nephropathy and membranous nephropathy.
- Hypertension, hyperuricemia, glomerulosclerosis, and intrarenal arterial lesions were independent predictors of adverse outcomes.
- Patients receiving antiviral therapy showed a significantly better prognosis than those who did not.
Conclusions:
- HBV-GN has distinct clinicopathological features and is not a benign condition in adults.
- Hypertension, hyperuricemia, glomerulosclerosis, and intrarenal arterial lesions are key prognostic predictors.
- Antiviral therapy can improve the long-term prognosis of HBV-GN patients.
Background:
Hepatitis B virus-associated glomerulonephritis is a common form of secondary glomerulonephritis in China. However, the clinicopathological features and long-term prognosis of Hepatitis B virus-associated Glomerulonephritis remain only partially known.
Methods:
Biopsy-proven Hepatitis B virus-associated Glomerulonephritis patients were enrolled between November 1994 and December 2013 at our center. The composite endpoints were doubling serum creatinine, end-stage renal disease, or death from renal disease during follow-up. The clinicopathological features and predictors of the long-term prognosis of Hepatitis B virus-associated Glomerulonephritis patients were explored.
Results:
The median age of the 259 Hepatitis B virus-associated Glomerulonephritis patients was 31.0 years (IQR 24.0-40.0), and 71.0% were males. Among the patients, 45.2% presented with nephrotic syndrome, and 45.9% presented with proteinuria combined with hematuria. The two most prevalent pathological patterns were IgA nephropathy (27.0%) and membranous nephropathy (27.0%). The mean follow-up period was 68.8 ± 46.9 months. The 3-, 5-, and 10-year clinical event-free survival rates were 93.4%, 85.2%, and 70.3%, respectively. Multivariable Cox regression analysis showed that hypertension (HR 2.580, 95% CI 1.351-4.927, P = 0.004), hyperuricemia (HR 2.101, 95% CI 1.116-3.954, P = 0.021), glomerulosclerosis (P = 0.001), and intrarenal arterial lesions (P = 0.041) were independent predictors of composite clinical event endpoint. Patients in the antiviral therapy group exhibited a significantly better prognosis compared to those who received no antiviral therapy (log-rank χ2 = 5.772, P = 0.016).
Conclusion:
Hepatitis B virus-associated Glomerulonephritis has specific clinicopathologic features and should not be considered a benign disease in adults. Hypertension, hyperuricemia, glomerulosclerosis, and intrarenal arterial lesions were independent predictors of the long-term prognosis in Hepatitis B virus-associated Glomerulonephritis patients. Antiviral therapy could be effective in improving the long-term prognosis of Hepatitis B virus-associated Glomerulonephritis patients.
More Related Videos
11:54Measurement of BK-polyomavirus Non-Coding Control Region Driven Transcriptional Activity Via Flow Cytometry
Published on: July 13, 2019
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
Related Concept Videos
Acute Kidney Injury III: Clinical Manifestations
Renal Corpuscle
Glomerulus: Structure and Function
The glomerulus is a tiny, intricate network of capillaries located at the beginning of the nephron. It's enveloped by the Bowman's capsule and receives its blood supply from an afferent arteriole, which divides into numerous...
Chronic Kidney Disease I: Introduction
Nephrotic Syndrome I : Introduction
Nephrons
Acute Kidney Injury II: Pathophysiology